APTAPHARMA, INC
US H-1B Labor Condition Application activity for APTAPHARMA, INC. Filed 48 disclosures between FY2010 and FY2026 from worksites with a NJ headquarters indicator.
H-1B outcome breakdown
Share of APTAPHARMA, INC’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 87.5% |
| Cert-withdrawn | 2.1% |
| Withdrawn | 4.2% |
| Denied | 6.3% |
Top occupations sponsored
SOC codes filed most by APTAPHARMA, INC across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 19-2031 | Chemists | 35 |
| 2 | 15-1253 | Software Quality Assurance Analysts and Testers | 3 |
| 3 | 19-2012 | Physicists | 2 |
| 4 | 13-1041 | Compliance Officers | 2 |
| 5 | 19-1012 | Food Scientists and Technologists | 1 |
| 6 | 19-4021 | Biological Technicians | 1 |
| 7 | 13-1161 | Market Research Analysts and Marketing Specialists | 1 |
| 8 | 13-2051 | Financial and Investment Analysts | 1 |
| 9 | 17-2112 | Industrial Engineers | 1 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2010 | 4 |
| FY2011 | 1 |
| FY2013 | 4 |
| FY2014 | 2 |
| FY2015 | 3 |
| FY2016 | 9 |
| FY2017 | 5 |
| FY2018 | 4 |
| FY2019 | 7 |
| FY2023 | 1 |
| FY2024 | 2 |
| FY2025 | 5 |
| FY2026 | 1 |
| Period | Value |
|---|---|
| FY2010 | 4 |
| FY2011 | 1 |
| FY2013 | 4 |
| FY2014 | 2 |
| FY2015 | 3 |
| FY2016 | 9 |
| FY2017 | 5 |
| FY2018 | 4 |
| FY2019 | 7 |
| FY2023 | 1 |
| FY2024 | 2 |
| FY2025 | 5 |
| FY2026 | 1 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.